ADIM
USNA icon

Alpha DNA Investment Management’s Usana Health Sciences USNA Stock Holding History

Alpha DNA Investment Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-110
Closed -$8K – 783
2020
Q4 		$8K Buy
+110
New +$8.51K 0.01% 330

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Alpha DNA Investment Management's USNA Position: Q1 2021 in Review

Alpha DNA Investment Management sold out of Usana Health Sciences (USNA) in Q1 2021, closing a stake of 110 shares — an estimated $8K sold.

Alpha DNA Investment Management first reported a position in USNA in Q4 2020 and held it in 1 quarter. The position peaked at $8K in Q4 2020. 198 funds tracked by Wall St. Rank hold USNA as of Q1 2021.

  • Alpha DNA Investment Management reported no remaining Usana Health Sciences position as of Q1 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 110 Usana Health Sciences shares in Q1 2021, an estimated $8K.
  • Alpha DNA Investment Management first reported a position in Usana Health Sciences in Q4 2020 and held it in 1 quarter.
  • Alpha DNA Investment Management's Usana Health Sciences position peaked at $8K in Q4 2020.
  • 198 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2021.

Based on Alpha DNA Investment Management's 13F filing for Q1 2021, filed 12 May 2021.